Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{157232,
        author = {Nidhi Sharma},
        title = {The role of Gliclazide in metabolism},
        journal = {International Journal of Innovative Research in Technology},
        year = {},
        volume = {9},
        number = {6},
        pages = {399-401},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=157232},
        abstract = {Gliclazide is an oral antihyperglycemic agent which is used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). Gliclazide belongs to the sulfonylurea class of insulin secretagogues, which act by stimulating β cells of the pancreas to release insulin molecules. Gliclazide is extensively metabolized by the liver; its metabolites are excreted in both urine (60-70%) and feces (10-20%).},
        keywords = {NIDDM, Hemoglobin, Nutrients, Gliclazide, Metabolism, Sulphonyl group.},
        month = {},
        }